MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLUMIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLUMIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU

MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU

No trades
See on Supercharts

MIRAE ASSET SECURITIES CO LTD TIGER GLOBAL OBESITY TREATMENT TOP 2 PLU holdings


As of July 31, 2025
Symbol
Weight %
Shares
Market value
L
LLYEli Lilly and Company
26.58%
‪‪14.13 K‬‬
‪‪14.51 B‬‬KRW
N
NVONovo Nordisk A/S Sponsored ADR Class B
17.53%
‪‪146.54 K‬‬
‪‪9.57 B‬‬KRW
A
ABBVAbbVie, Inc.
12.02%
‪‪25.02 K‬‬
‪‪6.56 B‬‬KRW
R
RORoche Holding Ltd
9.19%
‪‪10.77 K‬‬
‪‪5.02 B‬‬KRW
A
AZNAstraZeneca PLC Sponsored ADR
8.52%
‪‪45.89 K‬‬
‪‪4.65 B‬‬KRW
N
NVSNovartis AG Sponsored ADR
7.97%
‪‪27.56 K‬‬
‪‪4.35 B‬‬KRW
M
MRKMerck & Co., Inc.
7.38%
‪‪37.16 K‬‬
‪‪4.03 B‬‬KRW
A
AMGNAmgen Inc.
5.82%
‪‪7.76 K‬‬
‪‪3.18 B‬‬KRW
4
4519Chugai Pharmaceutical Co., Ltd.
2.93%
‪‪23.54 K‬‬
‪‪1.60 B‬‬KRW
R
REGNRegeneron Pharmaceuticals, Inc.
2.15%
‪‪1.55 K‬‬
‪‪1.17 B‬‬KRW
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.